Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyCarolina Behavioral Sepsis Update | OpenPayer
    Ask Trek AI about this page
    ModifiedCarolina Behavioral HealthPolicy CP.MP.85

    Neonatal Sepsis Management

    Customize your policy alerts

    Sign up for carolinabehavioralhealth Policy CP.MP.85 alerts

    Get alerted when Policy CP.MP.85 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medically necessary level of care, evaluation, antimicrobial treatment, monitoring, and discharge planning for newborns at risk for or diagnosed with neonatal sepsis, including perinatal Group B streptococcus prevention and management.

    Policy Summary
    PayerCarolina Behavioral Health
    PolicyNeonatal Sepsis Management
    Policy CodePolicy CP.MP.85
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionBefore discharge, document clinical stability, adequacy of the home situation, caregiver agreement, and provider follow-up scheduled within 48 hours.
    SourceLink
    POLICY UPDATE CHANGES

    The episode Day 1 criteria now identify both level I and level II nurseries as appropriate settings for well-appearing infants receiving 48 hours of antibiotics while awaiting blood culture results.

    Revenue codes were removed from the policy criteria and consolidated into a nursery-level reference table.

    48 hoursAntibiotic observation period
    36–48 hoursDiscontinue antibiotics when cultures are sterile and no site-specific infection exists
    ≥35 weeksGestational-age threshold for risk-based management

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ≤34 weeksHigher-risk preterm group
    100.4°F / 96.8°FTemperature thresholds for level III placement
    48 hoursPost-discharge follow-up window

    Neonatal Sepsis Level-of-Care and Treatment Criteria

    Episode Day 1 Level of Care

    Management of neonatal sepsis is medically necessary at the indicated level of care when ANY of the following Episode Day 1 pathways apply:

    ANY of the following

    • Well-appearing infant

      • Infant is well-appearing and remains on 48 hours of antibiotics pending blood culture results.

        Appropriate for a Level I or Level II nursery.

    • Symptomatic infant

      • Signs of neonatal sepsis are present, such as hypotonia, lethargy, poor oral feeding, tachycardia, bradycardia, grunting, nasal flaring, or cyanosis.
      • Temperature is >= 100.4 °F or <= 96.8 °F (>= 38.0 °C or <= 36.0 °C).
      • Infant is receiving 48 hours of antibiotics pending blood culture results or is being treated for positive blood cultures.

        Appropriate for a Level III nursery when all symptomatic-infant criteria are met.

    Episode Day 2 and Subsequent Days Level of Care

    For Episode Day 2 and subsequent days, the medically necessary level of care is determined by ANY of the following pathways:

    ANY of the following

    • Negative cultures with antibiotics continued

      • Blood cultures are negative and the infant is determined to require antibiotics beyond 48 hours.
      • Antibiotics are the only intervention necessitating continued stay.
      • Outpatient antibiotics are inappropriate or unmanageable.

        Appropriate for transitional care or a Level I nursery.

    • Symptomatic infant

      • Signs of neonatal sepsis are present, such as hypotonia, lethargy, poor oral feeding, tachycardia, bradycardia, grunting, nasal flaring, or cyanosis.

    Discharge With or Without Home Antibiotics

    Discharge, with or without home antibiotics, is medically appropriate when ALL applicable criteria are met:

    ALL applicable criteria

    • Member/enrollee is clinically stable.
    • Home situation is assessed and deemed adequate.
    • Parent or caretaker is agreeable with the plan of care.
    • If going home with antibiotics

      • A contractual agreement of care is signed with a home infusion company experienced in neonatal IV therapy or short-term intramuscular therapy.
      • Secure IV access is in place, if chosen.

    Antibiotic Duration and Care Transition

    Antibiotic duration and transition of care must follow ALL applicable criteria below:

    Duration and care transition

    • For ruling out sepsis due to perinatal risk factors, antibiotics are administered for 36 to 48 hours pending culture results and evaluation of laboratory data.
    • When blood cultures are sterile, antibiotic therapy is discontinued by 36 to 48 hours of incubation unless there is clear evidence of site-specific infection.
    • A stable infant at 35 weeks gestational age or older who is treated for sepsis is discharged the same day antibiotics are discontinued.
    • Once culture and sensitivity results are known and antibiotic therapy is established, a medically stable infant is transitioned to a lower level of care for treatment completion when no other indication requires the current level of care.

    Unless symptomatic GBS urinary tract infection is present or GBS bacteriuria exceeds 105 colony-forming units (CFU)/mL, antimicrobial agents should not be used before the intrapartum period solely to eradicate GBS genitourinary or rectal colonization, because this approach has not been shown to improve outcomes for the birthing individual or neonate.

    Necessary obstetric interventions should not be delayed solely to provide four hours of antibiotic administration before birth.

    Nursery Coding and Clinical Thresholds

    Nursery level revenue codesRevenue
    171Revenue code for Level II nursery
    173Revenue code for Level III nursery
    Temperature for symptomatic level III placement
    Upper temperature threshold≥100.4°F (≥38.0°C)
    Lower temperature threshold≤96.8°F (≤36.0°C)
    Applicable settingSymptomatic infants meeting the clinical criteria are appropriate for a level III nursery.
    Routine GBS screening
    Screening start36 0/7 weeks gestation
    Screening end37 6/7 weeks gestation
    Screening population

    Documentation and Discharge Responsibilities

    Documentation Required

    Document Discharge and Home Antibiotic Readiness

    Document that discharge, with or without home antibiotics, is appropriate only when the infant is clinically stable, the home situation is adequate, the parent or caretaker agrees with the plan of care, and provider follow-up is scheduled within 48 hours of discharge.

    • For discharge with antibiotics, document a signed contractual agreement with a home infusion company experienced in neonatal IV therapy or short-term intramuscular therapy.
    • Document that secure IV access is in place when applicable.
    • Provide the responsible physician’s contact information and the back-up health care facility (NICU or community hospital) to the family and home care agency before discharge.
    • If IV antibiotics cannot be safely administered at home or with home health care, consider transitional care nursery.
    • After culture and sensitivity results are known and antibiotic therapy is established, transition a medically stable infant to a lower level of care for treatment completion when no other indication requires the current level of care.
    Documentation Required

    Document Level-of-Care Justification

    Neonatal Sepsis and GBS Context

    Early-onset neonatal sepsis has become less frequent with increased intrapartum antibiotic use but remains an important cause of neonatal morbidity and mortality. Group B streptococcus is a leading cause of early-onset disease and a major cause of late-onset disease. Management requires risk-based newborn assessment, timely antimicrobial treatment when indicated, appropriate nursery level, and discharge planning. Common laboratory tests, including CBC and C-reactive protein, have limited predictive performance in low-risk, well-appearing infants, and procalcitonin is not definitive for ruling in or ruling out neonatal infection.

    Clinical Definitions and Care Settings

    GBS early-onset disease
    ConditionGBS early-onset disease
    ConfirmationBlood or cerebrospinal fluid culture-proven infection
    TimingOccurring within the first six days of life
    GBS late-onset disease
    ConditionGBS late-onset disease
    ConfirmationIsolation of GBS from a normally sterile site
    TimingFrom seven through 89 days of age
    Policy Summary
    PayerCarolina Behavioral Health
    PolicyNeonatal Sepsis Management
    Policy CodePolicy CP.MP.85
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionBefore discharge, document clinical stability, adequacy of the home situation, caregiver agreement, and provider follow-up scheduled within 48 hours.
    SourceLink
    On This Page
    Neonatal Sepsis Level-of-Care and Treatment CriteriaNursery Coding and Clinical ThresholdsDocumentation and Discharge ResponsibilitiesNeonatal Sepsis and GBS ContextClinical Definitions and Care Settings
  1. Temperature is >= 100.4 °F or <= 96.8 °F (>= 38.0 °C or <= 36.0 °C).
  2. Infant is receiving 48 hours of antibiotics pending blood culture results or is being treated for positive blood cultures.

    Appropriate for a Level III nursery when all symptomatic-infant criteria are met.

  3. Asymptomatic infant pending culture result

    • Infant is asymptomatic and is receiving 48 hours of antibiotics pending blood culture results for no more than two days.

      Appropriate for a Level II nursery.

  4. Asymptomatic infant with positive culture

    • Infant is asymptomatic and has a positive blood culture with no other indications requiring a higher level of care.

      Appropriate for transitional care.

  5. Transition after culture and sensitivity results

    • Culture and sensitivity results are known and antibiotic therapy is established.
    • Infant is medically stable.
    • No other indication exists that requires the current level of care.

      Transition the infant to a lower level of care for treatment completion.

  6. Contact information for the responsible physician, such as a neonatologist or primary care pediatrician, and a back-up health care facility, such as a NICU or community hospital, is provided to the family and home care agency before discharge.
  7. Provider follow-up is scheduled within 48 hours of discharge.
  8. Transitional care nursery is considered when antibiotics cannot safely be administered at home or with home health care.

    Intravenous antibiotics can be difficult to administer at home because very small catheters may be difficult to keep in place and patent.

    All other pregnant individuals, including those with a scheduled cesarean delivery, should be screened for vaginal and rectal GBS colonization.
    Gestational age for newborn risk pathways
    Infants at or above 35 weeksManage according to risk using categorical risk assessment, clinical condition, or multivariate risk assessment.
    Infants at or below 34 weeksPreterm infants are assessed as highest or lower risk according to the circumstances of preterm birth and delivery.
    Highest-risk circumstancesCervical insufficiency, preterm labor, premature rupture of membranes, intraamniotic infection, or acute otherwise unexplained nonreassuring fetal status identify the highest-risk pathway.
    GBS bacteriuria threshold
    Bacteriuria threshold>10^5 colony-forming units (CFU)/mL
    Use before the intrapartum periodAntimicrobial agents should not be used solely to eradicate GBS genitorectal colonization unless this threshold is exceeded or symptomatic GBS UTI is present.
    Clinical implicationGBS bacteriuria during pregnancy exceeding the threshold is an indication for intrapartum antibiotic prophylaxis.
    Term rupture of membranes risk threshold
    Term ROM threshold≥18 hours
    Applies whenScreening results are not available at the time of labor and delivery.
    ActionIntrapartum antibiotics should be given when term rupture of membranes lasts at least 18 hours.

    Document the clinical facts supporting the indicated level of care, including symptoms, temperature, culture status, antibiotic status, and the rationale for continued hospitalization or transition to a lower level of care.

    • For symptomatic infants requiring level III nursery care, document signs of neonatal sepsis (for example, hypotonia, lethargy, poor oral feeding, tachycardia, bradycardia, grunting, nasal flaring, or cyanosis), temperature ≥ 100.4°F (≥ 38.0°C) or ≤ 96.8°F (≤ 36.0°C), and either 48 hours of antibiotics pending blood culture results or treatment of positive blood cultures.
    • On episode day 1, document why a well-appearing infant on 48 hours of antibiotics pending blood culture results is appropriate for a level I or level II nursery.
    • On episode day 2 and subsequent days, document why an infant with negative cultures requires antibiotics beyond 48 hours, why antibiotics are the only intervention necessitating continued stay, and why outpatient antibiotics are inappropriate or unmanageable when transitional care or level I nursery is used.
    • Document that an asymptomatic infant receiving 48 hours of antibiotics pending blood culture results for no more than two days is appropriate for a level II nursery, and that an asymptomatic infant with a positive blood culture and no other indications is appropriate for transitional care.
    • Document culture and susceptibility follow-up, the established antibiotic plan, and the reason for continued current-level care versus transition to transitional care or a lower level of care.
    Level I nursery
    Nursery levelLevel I nursery
    Appropriate forWell-appearing infants receiving 48 hours of antibiotics pending blood culture results
    Additional useCertain asymptomatic infants receiving short antibiotic courses
    Transitional care
    Care settingA lower-acuity nursery setting
    Appropriate forCertain asymptomatic or culture-negative infants needing continued antibiotics
    When to considerWhen antibiotics cannot safely be administered at home or with home health care